Queen Elizabeth University Hospital Birmingham
Birmingham, United Kingdom
NCT Number: NCT02949505
A UK prospective, single-centre feasibility study investigating the effects of exercise therapy on functional capacity in patients on the waiting list for liver transplantation. Patients will receive a 12-week home prehabilitation program (daily step program; functional resistance exercise sessions; telephone health call or virtual clinic). The following will be assessed at weeks 0, 6 and 12 weeks: feasibility (recruitment, compliance, safety, patients perception), functional capacity (ISWT, SPBT), psychological wellbeing (HADS questionnaire) and quality of life (EQ-5D)
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Birmingham, United Kingdom
as above
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12-week exercise therapy using daily step program (accelerometer), functional resistance exercise sessions and telephone/virtual clinic appointments
Time frame: 12-week
As this is a feasibility/Pilot study the investigators need to assess if any participants have any adverse events related to the home prehabilitation programme and if so, determine the severity and frequency
Time frame: 12-weeks
incremental shuttle walk test
Time frame: 12-weeks
Time frame: 12-weeks
HADS questionnaire
Time frame: 12-weeks
EQ-5D questionnaire
Matthew Armstrong
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07561138
Atrophy, Behavior
Athens, Attica, Greece
View Trial DetailsNCT05080465
Digestive System Diseases, Fibrosis
Kharkiv, Ukraine
View Trial DetailsNCT04987034
Digestive System Diseases, End Stage Liver Disease
Leuven, Belgium
View Trial DetailsNCT04782050
Digestive System Diseases, Fatty Liver
Pessac, France
View Trial Details